| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4371861 | Experimental Parasitology | 2007 | 4 Pages |
Abstract
Plasma samples from patients undergoing treatment in malaria endemic countries often contain anti-malaria drugs, that may overstate effects of specific antibodies in growth inhibition assays (GIA). We describe a modified assay that uses drug resistant P. falciparum parasites (W2) that circumvents the requirement for dialyzing samples that may likely contain drugs such as chloroquine and sulfadoxine/pyrimethamine (SP).
Related Topics
Life Sciences
Immunology and Microbiology
Parasitology
Authors
Godfree Mlambo, Nirbhay Kumar,